Abstract
Introduction We aimed to investigate associations between common infections and neuroimaging markers of dementia risk (brain volume, hippocampal volume, white matter lesions) across three population-based studies.
Methods We tested associations between serology measures (pathogen serostatus, cumulative burden, continuous antibody responses) and outcomes using linear regression, including adjustments for total intracranial volume and scanner/clinic information (basic model), age, sex, ethnicity, education, socioeconomic position, alcohol, BMI, and smoking (fully adjusted model). Interactions between serology measures and APOE genotype were tested. Findings were meta-analysed across cohorts (Nmain=2632; NAPOE-interaction=1810).
Results Seropositivity to JC virus associated with smaller brain volumes in basic models (ß=-3.89ml[-5.81,-1.97],padjusted<0.05); these were largely attenuated in fully adjusted models (ß=-1.59ml[-3.55,0.36], p=0.11). No other relationships were robust to multiple testing correction and sensitivity analyses, but several suggestive associations were observed.
Discussion We did not find clear evidence for relationships between common infections and markers of dementia risk. Some suggestive findings warrant testing for replication.
Competing Interest Statement
JMS has received research funding and PET tracer from AVID Radiopharmaceuticals (a wholly owned subsidiary of Eli Lilly) and Alliance Medical; has consulted for Roche, Eli Lilly, Biogen, AVID, Merck and GE; and received royalties from Oxford University Press and Henry Stewart Talks. He is Chief Medical Officer for Alzheimer's Research UK. NC receives funds from AstraZeneca for serving on data safety and monitoring committees for clinical trials of glucose lowering agents.
Funding Statement
This research was supported by funding from the British Heart Foundation (PG/21/10776), the UK Medical Research Council (MC_UU_00019/1; MC_UU_00019/2; MC_UU_00019/3) and Open Philanthropy. CHS is supported by an Alzheimer's Society Junior Fellowship (AS-JF-17-011). CWG is supported by a Wellcome Career Development Award (225868/Z/22/Z).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All cohorts received ethical approval and all participants provided written informed consent. The NSHD and its sub-study Insight 46 received approval from the National Research Ethics Service Committee London (14/LO/1173), SABRE from the St Mary's Hospital Research Ethics Committee (07/H0712/109), and UKB from the NHS North West Research Ethics Committee (11/NW/0382).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Per-study results are available on request.
Abbreviations
- AD
- Alzheimer’s disease
- APOE
- Apolipoprotein E
- BaMoS
- Bayesian Model Selection
- BMI
- Body mass index
- CMV
- Cytomegalovrius
- EBV
- Epstein-Barr virus
- HHV
- Human herpesvirus
- HPV
- Human papillomavirus
- HSV
- Herpes simplex virus
- IgG
- Immunoglobulin G
- JC
- John-Cunningham virus
- KSHV
- Kaposi’s sarcoma-associated herpesviruses
- MCV
- Merkel Cell virus
- NSHD
- National Survey of Health and Development
- PBI
- Pathogen burden index
- QC
- Quality control
- SABRE
- Southall and Brent Revisited
- UKB
- UK Biobank
- VZV
- Varicella zoster virus